Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating Activities
Net income	$ 21,888	$ 19,833
Adjustments to reconcile net income to net cash provided (used) by operating activities
Deferred income taxes	149	(1,907)
Provision for loan losses	5,515	7,080
Depreciation and amortization	6,503	6,591
Amortization and accretion of premiums/discounts on investment securities	832	1,227
Stock-based compensation	1,330	982
Increase in value of bank-owned life insurance	(601)	(602)
Realized loss (gain) on sale of branch	(1,544)
Realized loss (gain) on sale of fixed assets	(541)
Realized loss (gain) on forward sale derivatives	(7)
Realized loss (gain) on rate lock commitments	12	(24)
Realized loss (gain) on sale of foreclosed assets	(120)	187
Realized loss (gain) on sale of investment securities	(379)	(135)
Realized loss (gain) on servicing rights	(213)	(497)
Net change in:
Securities held for trading	1,539	51
Loans held for sale	(51,535)	(9,734)
Accrued interest receivable	151	(993)
Other assets	3,287	6,707
Accrued expenses and other liabilities	15,666	(1,417)
Net cash provided (used) by operating activities	1,932	27,349
Investing Activities
Proceeds from sales of investment securities available-for-sale	32,565	2,466
Proceeds from maturities of investment securities available-for-sale	27,818	26,120
Purchases of investment securities available-for-sale	(80,450)	(10,493)
Net (increase) decrease in equity securities	490	2,698
Net (increase) decrease in loans	14,213	(153,475)
Proceeds from sale of branch	10,379
Proceeds from sale of fixed assets	875
Purchases of premises and equipment	(2,450)	(2,314)
Proceeds from sales of foreclosed assets	1,006	687
Net cash provided (used) by investing activities	4,446	(134,311)
Financing Activities
Net increase (decrease) in deposits	53,241	(17,253)
Net increase (decrease) in short-term borrowings	(93,460)	43,930
Repayments of long-term debt	(181)	(128)
Cash dividends paid on common stock	(6,312)	(5,486)
Repurchase of common stock	(1,947)	(262)
Proceeds from the issuance of common stock in initial public offering net of issuance costs	62,804
Net cash provided (used) by financing activities	14,145	20,801
Net change in cash and cash equivalents	20,523	(86,161)
Cash and cash equivalents at beginning of period	40,651	121,998
Cash and cash equivalents at end of period	61,174	35,837
Cash paid for:
Interest	13,162	7,692
Income taxes	5,550	3,030
Non‑cash information
Loan collateral transferred to foreclosed assets	766	661
Unrealized gain (loss) on investment securities available-for-sale	6,686	(4,579)
Initial recognition of operating lease right‑of‑use assets	10,475
Initial recognition of operating lease liabilities	10,996
Change in fair value of ESOP shares		$ (3,003)
ESOP repurchase obligation termination	$ 34,494